NCT00526188 - Efficacy and Safety of Primovist in Chinese Patients | Biotech Hunter

Enrollment

234

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Known or Suspected Focal Liver Lesions

Interventions

DRUG

Gadoxetic Acid Disodium (Primovist, BAY86-4873)

Bolus injection of 0.025 mmol/kg body weight (0.1 ml/kg BW) of Gadoxetic Acid Disodium (Primovist, BAY86-4873). Single i.v. injection during MRI procedure, with one contrast-enhanced MRI procedure per patient

Trial Locations (6)

100853

Beijing

200032

Shanghai

200433

Shanghai

210009

Nanjing

215006

Suzhou

710032

Xi'an